The Urinary Tract Plus Simplicity PanelTM is an in-vitro multiplex real-time polymerase chain reaction (RT-PCR) assay for the qualitative identification of nucleic acids from organisms frequently found in the urinary tract. This method is highly accurate, extremely sensitive, and is used to identify organisms by amplifying and detecting genetic material of pathogens in samples. The panel will aid in the research of causative agents of urinary tract infections and their prevalence.
The target organisms included in the panel are as follows:
Acinetobacter baumannii, Bacteroides fragilis, Candida albicans, Candida dubliniensis, Candida glabrata, Candida krusei, Candida parapsilosis, Candida tropicalis, Citrobacter freundii, Citrobacter koseri, Enterobacter cloacae, Enterococcus spp., Escherichia coli, Klebsiella aerogenes, Klebsiella oxytoca, Klebsiella pneumoniae, Morganella morganii, Mycoplasma genitalium, Mycoplasma hominis, Prevotella bivia, Proteus mirabilis, Pseudomonas aeruginosa, Serratia marcescens, Staphylococcus aureus, Staphylococcus epidemidis, Staphylococcus saprophyticus, Streptococcus agalactiae (Group B), Streptococcus pyogenes (Group A), and Ureaplasma urealyticum.
Antibiotic Resistance Markers present
are as follows: β-lactamase (blaKPC), β-lactamase (CTX-M-Group 1), metallo-β-lactamase (blaNDM), Fluoroquinolones (qnr), Methicillin/Oxacillin (mecA), Sulfonamides (sul), Trimethoprim (dfrA), and Vancomycin (vanA, vanB).
|Reagent Storage and Use Guidelines|
|The Following is Included in the Kit|
|The Following is Supplied by the User:
|CFX96 Touch Real-Time PCR Detection
System (or equivalent)
Download Product Information
Limitations of Use
Molecular Designs products are for Research Use Only and intended for molecular biology applications. This product is not intended for the diagnosis, prevention or treatment of a disease.
Disclaimer - Use of PCR and Patent
This product is for basic PCR and is outside of any valid US patents assigned to Hoffman La-Roche.